Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04381650
Title A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Takeda

lung small cell carcinoma

cervical squamous cell carcinoma

head and neck squamous cell carcinoma

cervical adenocarcinoma

lung non-small cell carcinoma

cervical adenosquamous carcinoma

colorectal cancer

skin melanoma


Pembrolizumab + Subasumstat

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.